ProteoNic Announces Licensing of its Premium 2G UNic™ Technology Platform for Production of Biologic
LEIDEN, the Netherlands and BERLIN, Germany, July 05, 2022 / B3C newswire / -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, and FyoniBio GmbH, a contract development organization for biopharmaceuticals, today announced they have entered into a...
Source: pharmiweb.com
